|
1
|
Ogdie A, Yu Y, Haynes K, Love TJ, Maliha
S, Jiang Y, Troxel AB, Hennessy S, Kimmel SE, Margolis DJ, et al:
Risk of major cardiovascular events in patients with psoriatic
arthritis, psoriasis and rheumatoid arthritis: A population-based
cohort study. Ann Rheum Dis. 74:326–332. 2015. View Article : Google Scholar :
|
|
2
|
Chi CC, Wang J, Chen YF, Wang SH, Chen FL
and Tung TH: Risk of incident chronic kidney disease and end-stage
renal disease in patients with psoriasis: A nationwide
population-based cohort study. J Dermatol Sci. 78:232–238. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wan J, Wang S, Haynes K, Denburg MR, Shin
DB and Gelfand JM: Risk of moderate to advanced kidney disease in
patients with psoriasis: Population based cohort study. BMJ.
347:f59612013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ganzetti G, Campanati A and Offidani A:
Non-alcoholic fatty liver disease and psoriasis: So far, so near.
World J Hepatol. 7:315–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang CQ, Suarez-Farinas M, Nograles KE,
Mimoso CA, Shrom D, Dow ER, Heffernan MP, Hoffman RW and Krueger
JG: IL-17 induces inflammation-associated gene products in blood
monocytes, and treatment with ixekizumab reduces their expression
in psoriasis patient blood. J Invest Dermatol. 134:2990–2993. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ilkovitch D: Role of immune-regulatory
cells in skin pathology. J Leukoc Biol. 89:41–49. 2011. View Article : Google Scholar :
|
|
7
|
Ilkovitch D and Lopez DM:
Urokinase-mediated recruitment of myeloid-derived suppressor cells
and their suppressive mechanisms are blocked by MUC1/sec. Blood.
113:4729–4739. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bronte V, Brandau S, Chen SH, Colombo MP,
Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A,
Ostrand-Rosenberg S, et al: Recommendations for myeloid-derived
suppressor cell nomenclature and characterization standards. Nat
Commun. 7:121502016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gabrilovich DI, Bronte V, Chen SH, Colombo
MP, Ochoa A, Ostrand-Rosenberg S and Schreiber H: The terminology
issue for myeloid-derived suppressor cells. Cancer Res. 67:425–426.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu C, Yu S, Kappes J, Wang J, Grizzle WE,
Zinn KR and Zhang HG: Expansion of spleen myeloid suppressor cells
represses NK cell cytotoxicity in tumor-bearing host. Blood.
109:4336–4342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sinha P, Clements VK, Bunt SK, Albelda SM
and Ostrand-Rosenberg S: Cross-talk between myeloid-derived
suppressor cells and macrophages subverts tumor immunity toward a
type 2 response. J Immunol. 179:977–983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ilkovitch D and Lopez DM: The liver is a
site for tumor-induced myeloid-derived suppressor cell accumulation
and immunosuppression. Cancer Res. 69:5514–5521. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang B, Pan PY, Li Q, Sato AI, Levy DE,
Bromberg J, Divino CM and Chen SH: Gr-1+CD115+ immature myeloid
suppressor cells mediate the development of tumor-induced T
regulatory cells and T-cell anergy in tumor-bearing host. Cancer
Res. 66:1123–1131. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Youn JI, Nagaraj S, Collazo M and
Gabrilovich DI: Subsets of myeloid-derived suppressor cells in
tumor-bearing mice. J Immunol. 181:5791–5802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Filipazzi P, Valenti R, Huber V, Canese P,
Iero M, Castelli C, Mariani L, Parmiani G and Rivoltini L:
Identification of a new subset of myeloid suppressor cells in
peripheral blood of melanoma patients with modulation by a
granulocyte-macrophage colony-stimulation factor-based antitumor
vaccine. J Clin Oncol. 25:2546–2553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Diaz-Montero CM, Salem ML, Nishimura MI,
Garrett-Mayer E, Cole DJ and Montero AJ: Increased circulating
myeloid-derived suppressor cells correlate with clinical cancer
stage, metastatic tumor burden, and doxorubicin-cyclophosphamide
chemotherapy. Cancer Immunol Immunother. 58:49–59. 2009. View Article : Google Scholar
|
|
17
|
Almand B, Clark JI, Nikitina E, van Beynen
J, English NR, Knight SC, Carbone DP and Gabrilovich DI: Increased
production of immature myeloid cells in cancer patients: A
mechanism of immunosuppression in cancer. J Immunol. 166:678–689.
2001. View Article : Google Scholar
|
|
18
|
Kusmartsev S, Su Z, Heiser A, Dannull J,
Eruslanov E, Kübler H, Yancey D, Dahm P and Vieweg J: Reversal of
myeloid cell-mediated immunosuppression in patients with metastatic
renal cell carcinoma. Clin Cancer Res. 14:8270–8278. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoechst B, Ormandy LA, Ballmaier M, Lehner
F, Krüger C, Manns MP, Greten TF and Korangy F: A new population of
myeloid-derived suppressor cells in hepatocellular carcinoma
patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology.
135:234–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Haile LA, von Wasielewski R,
Gamrekelashvili J, Krüger C, Bachmann O, Westendorf AM, Buer J,
Liblau R, Manns MP, Korangy F and Greten TF: Myeloid-derived
suppressor cells in inflammatory bowel disease: A new
immunoregulatory pathway. Gastroenterology. 135:871–881. e1–5.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Makarenkova VP, Bansal V, Matta BM, Perez
LA and Ochoa JB: CD11b+/Gr-1+ myeloid suppressor cells cause T cell
dysfunction after traumatic stress. J Immunol. 176:2085–2094. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Noel JG, Osterburg A, Wang Q, Guo X, Byrum
D, Schwemberger S, Goetzman H, Caldwell CC and Ogle CK: Thermal
injury elevates the inflammatory monocyte subpopulation in multiple
compartments. Shock. 28:684–693. 2007.PubMed/NCBI
|
|
23
|
Delano MJ, Scumpia PO, Weinstein JS, Coco
D, Nagaraj S, Kelly-Scumpia KM, O'Malley KA, Wynn JL, Antonenko S,
Al-Quran SZ, et al: MyD88-dependent expansion of an immature
GR-1(+)CD11b(+) population induces T cell suppression and Th2
polarization in sepsis. J Exp Med. 204:1463–1474. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
De Santo C, Salio M, Masri SH, Lee LY,
Dong T, Speak AO, Porubsky S, Booth S, Veerapen N, Besra GS, et al:
Invariant NKT cells reduce the immunosuppressive activity of
influenza A virus-induced myeloid-derived suppressor cells in mice
and humans. J Clin Invest. 118:4036–4048. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dugast AS, Haudebourg T, Coulon F, Heslan
M, Haspot F, Poirier N, Vuillefroy de Silly R, Usal C, Smit H,
Martinet B, et al: Myeloid-derived suppressor cells accumulate in
kidney allograft tolerance and specifically suppress effector T
cell expansion. J Immunol. 180:7898–7906. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Soler DC, Young AB, Fiessinger L,
Galimberti F, Debanne S, Groft S, McCormick TS and Cooper KD:
Increased, but functionally impaired, CD14(+) HLA-DR(-/low)
myeloid-derived suppressor cells in psoriasis: A mechanism of
dysregulated T cells. J Invest Dermatol. 136:798–808. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang L, DeBusk LM, Fukuda K, Fingleton B,
Green-Jarvis B, Shyr Y, Matrisian LM, Carbone DP and Lin PC:
Expansion of myeloid immune suppressor Gr+CD11b+ cells in
tumor-bearing host directly promotes tumor angiogenesis. Cancer
Cell. 6:409–421. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nefedova Y, Fishman M, Sherman S, Wang X,
Beg AA and Gabrilovich DI: Mechanism of all-trans retinoic acid
effect on tumor-associated myeloid-derived suppressor cells. Cancer
Res. 67:11021–11028. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Talmadge JE and Gabrilovich DI: History of
myeloid-derived suppressor cells. Nat Rev Cancer. 13:739–752. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kotsakis A, Harasymczuk M, Schilling B,
Georgoulias V, Argiris A and Whiteside TL: Myeloid-derived
suppressor cell measurements in fresh and cryopreserved blood
samples. J Immunol Methods. 381:14–22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gehad AE, Lichtman MK, Schmults CD, Teague
JE, Calarese AW, Jiang Y, Watanabe R and Clark RA: Nitric
oxide-producing myeloid-derived suppressor cells inhibit vascular
E-selectin expression in human squamous cell carcinomas. J Invest
Dermatol. 132:2642–2651. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mendoza AE, Neely CJ, Charles AG,
Kartchner LB, Brickey WJ, Khoury AL, Sempowski GD, Ting JP, Cairns
BA and Maile R: Radiation combined with thermal injury induces
immature myeloid cells. Shock. 38:532–542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Marhaba R, Vitacolonna M, Hildebrand D,
Baniyash M, Freyschmidt-Paul P and Zöller M: The importance of
myeloid-derived suppressor cells in the regulation of autoimmune
effector cells by a chronic contact eczema. J Immunol.
179:5071–5081. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Skabytska Y, Wolbing F, Günther C, Köberle
M, Kaesler S, Chen KM, Guenova E, Demircioglu D, Kempf WE, Volz T,
et al: Cutaneous innate immune sensing of Toll-like receptor 2–6
ligands suppresses T cell immunity by inducing myeloid-derived
suppressor cells. Immunity. 41:762–775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guan Q, Moreno S, Qing G, Weiss CR, Lu L,
Bernstein CN, Warrington RJ, Ma Y and Peng Z: The role and
potential therapeutic application of myeloid-derived suppressor
cells in TNBS-induced colitis. J Leukoc Biol. 94:803–811. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Smith AR and Reynolds JM: Editorial: The
contribution of myeloid-derived suppression to inflammatory
disease. J Leukoc Biol. 96:361–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mizutani H, Ohmoto Y, Mizutani T, Murata M
and Shimizu M: Role of increased production of monocytes TNF-alpha,
IL-1beta and IL-6 in psoriasis: Relation to focal infection,
disease activity and responses to treatments. J Dermatol Sci.
14:145–153. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Okubo Y and Koga M: Peripheral blood
monocytes in psoriatic patients overproduce cytokines. J Dermatol
Sci. 17:223–232. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Melani C, Sangaletti S, Barazzetta FM,
Werb Z and Colombo MP: Amino-biphosphonate-mediated MMP-9
inhibition breaks the tumor-bone marrow axis responsible for
myeloid-derived suppressor cell expansion and macrophage
infiltration in tumor stroma. Cancer Res. 67:11438–11446. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ilkovitch D and Lopez DM: Immune
modulation by melanoma-derived factors. Exp Dermatol. 17:977–985.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen HW, Chen HY, Wang LT, Wang FH, Fang
LW, Lai HY, Chen HH, Lu J, Hung MS, Cheng Y, et al: Mesenchymal
stem cells tune the development of monocyte-derived dendritic cells
toward a myeloid-derived suppressive phenotype through
growth-regulated oncogene chemokines. J Immunol. 190:5065–5077.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mehra VC, Ramgolam VS and Bender JR:
Cytokines and cardiovascular disease. J Leukoc Biol. 78:805–818.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang YG, Xiong X, Chen ZY, Liu KL, Yang
JH, Wen Q, Wu FQ, Hu XF, Peng YD, Wu JJ, et al: Expansion of
myeloid-derived suppressor cells in patients with acute coronary
syndrome. Cell Physiol Biochem. 35:292–304. 2015. View Article : Google Scholar : PubMed/NCBI
|
